Syncope Disease

DESCRIPTION
Approximately 5-20% of adults will have one or more episodes of syncope by age 75. The disorder accounts for about 1% of hospital admissions and about 3% of emergency room visits. Its annual incidence in the institutionalized elderly is about 6%.
  • System(s) affected: Nervous, Cardiovascular
  • Genetics: N/A
  • Incidence/Prevalence in USA: 6% in persons over age 75 (incidence)
  • Predominant age: Elderly
  • Predominant sex: N/A
SIGNS AND SYMPTOMS
Transient loss of consciousness characterized by unresponsiveness, loss of postural tone, and spontaneous recovery
CAUSES
  • Cardiac - obstruction to outflow:
    • Aortic stenosis
    • Hypertrophic cardiomyopathy
    • Pulmonary embolus
  • Cardiac - arrhythmias:
    • Ventricular tachycardia
    • Sick sinus syndrome
    • 2nd and 3rd degree AV block
  • Non-cardiac:
    • Reflex mediated vasovagal, situational (micturition, defecation, cough)
    • Orthostatic hypotension
    • Drug induced
    • Neurologic: Seizures, transient ischemic attack
    • Carotid sinus
    • Psychogenic
RISK FACTORS
  • Patients with heart disease
  • Patients taking following drugs:
    • Antihypertensives
    • Vasodilators (including calcium channel blockers, ACE inhibitors, and nitrates)
    • Phenothiazines
    • Antidepressants
    • Antiarrhythmics
    • Diuretics
LABORATORY

Rarely helpful. Less than 2% have hyponatremia, hypocalcemia, hypoglycemia or renal failure causing seizures.

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS

N/A

SPECIAL TESTS
  • If history and physical suggestive of ischemic, valvular or congenital heart disease – echocardiogram, cardiac catheterization
  • If CNS disease suspected – EEG, head CT, head MRI. These tests should not be ordered unless there are hints of CNS disease on history or physical examination.
IMAGING

Lung scan or helical CT of the thorax if history and physical examination suggestive of pulmonary embolism

DIAGNOSTIC PROCEDURES
  • ECG monitoring, either in the hospital or ambulatory (Holter), is useful in 4–15% of patients. Arrhythmias are frequently documented, but rarely associated with syncope. Monitoring should be done in patients with heart disease, and in patients with recurrent syncope. Patient-activated intermittent loop recorders, which the patient activates after regaining consciousness, can record 4–5 minutes of retrograde ECG rhythm. These have been helpful in patients with recurrent syncope with a diagnostic yield between 24–47%.
  • Electrophysiologic studies (EPS) have been positive in 18–75% of patients. Induction of ventricular tachycardia and dysfunction of the His-Purkinje system are the two most common abnormalities. Although there is the problem of knowing whether the arrhythmia noted or induced during the study is the cause of syncope, EPS should be done in patients with heart disease or recurrent syncope.
  • The following findings are probable causes of syncope:
    • Sustained ventricular tachycardia
    • Sinus node recovery time 3 seconds or more
    • Pacing-induced infranodal block
    • H–V interval greater than 100 msec
  • Carotid hypersensitivity should be considered in patients with syncope on head turning, especially with head turning while wearing a tight collar, and in patients with neck tumors and neck tissue scars. The technique is not standardized. One side should be massaged at a time for 20 seconds with constant monitoring of pulse and blood pressure. Atropine should be readily available.
  • Tilt testing, with and without isoproterenol infusion, is a provocative test for vasovagal syncope which is not standardized, but has been reported positive (symptomatic hypotension and bradycardia) in 26–87% of patients. However, the test has been reported positive in 0–45% of control subjects. The role of this test in the workup of patients with syncope of unknown origin is not known, and should be done only in patients in which cardiac causes of syncope have been excluded. Patients with a positive tilt test often respond to beta-blocker treatment.
  • Psychiatric evaluation should be considered in patients with multiple episodes of syncope (greater than 5 per year) who do not have heart disease. Anxiety, depression, alcohol and drug abuse can be associated with syncope.
APPROPRIATE HEALTH CARE
  • Patients with heart disease should be admitted to the hospital for evaluation
  • Elderly patients without previously recognized heart disease should be admitted if the physician thinks that a cardiac cause of syncope is likely
  • Patients without heart disease, especially young patients (less than 60 years old), can be safely worked up as outpatients
GENERAL MEASURES

No specific measures

SURGICAL MEASURES

N/A

ACTIVITY

Fully active unless severe cardiac disease

DIET

No specific diet unless heart disease

PATIENT EDUCATION
  • Reassure the patient that most cardiac causes of syncope can be treated, and that patients with non-cardiac causes do well, even if the cause of syncope is never discovered
  • The physician and patient should carefully consider whether the patient should continue to drive while syncope is being evaluated. Physicians should be aware of the pertinent laws in their own state.
PREVENTION/AVOIDANCE

Avoid Risk factors

POSSIBLE COMPLICATIONS
  • Trauma from falling
  • Death – see prognosis
EXPECTED COURSE AND PROGNOSIS
  • Cumulative mortality at 2 years:
    • Low (2–5%) – young patients (< 60) with a non-cardiac cause or unknown cause of syncope.
    • Intermediate (20%) – older patients (> 60) with a non-cardiac or unknown cause of syncope.
    • High (32–38%) – patients with cardiac cause of syncope.
ASSOCIATED CONDITIONS

See Causes

AGE-RELATED FACTORS

Pediatric: Rare in this age group
Geriatric:More common in this age group, prognosis worse in older patients
Others: N/A

PREGNANCY

Pregnancy is a common time for onset of, or increase in obesity

OTHER NOTES

N/A

ABBREVIATIONS

RDA = recommended daily allowance
BMI = body mass index

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.